ArticleJTO clinical and research reports2022

RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With

Makoto Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.